150 related articles for article (PubMed ID: 20687102)
21. Mutation in TET2 in myeloid cancers.
Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
[TBL] [Abstract][Full Text] [Related]
22. Loss of STAG2 causes aneuploidy in normal human bladder cells.
Li X; Zhang TW; Tang JL; Fa PP; Lu JX; Qi FM; Cai ZM; Liu CX; Sun XJ
Genet Mol Res; 2015 Mar; 14(1):2638-46. PubMed ID: 25867412
[TBL] [Abstract][Full Text] [Related]
23. The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9.
Fisher JB; Peterson J; Reimer M; Stelloh C; Pulakanti K; Gerbec ZJ; Abel AM; Strouse JM; Strouse C; McNulty M; Malarkannan S; Crispino JD; Milanovich S; Rao S
Leukemia; 2017 Mar; 31(3):712-719. PubMed ID: 27554164
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring.
Xu F; Li X; Wu L; Zhang Q; Yang R; Yang Y; Zhang Z; He Q; Chang C
Ann Hematol; 2011 Jun; 90(6):643-53. PubMed ID: 21125401
[TBL] [Abstract][Full Text] [Related]
25. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
[TBL] [Abstract][Full Text] [Related]
26. Myelodysplastic syndromes: lost between two states?
Acquaviva C; Gelsi-Boyer V; Birnbaum D
Leukemia; 2010 Jan; 24(1):1-5. PubMed ID: 20068572
[No Abstract] [Full Text] [Related]
27. Mutation in TET2 in myeloid cancers.
Tefferi A; Lim KH; Levine R
N Engl J Med; 2009 Sep; 361(11):1117; author reply 1117-8. PubMed ID: 19741235
[No Abstract] [Full Text] [Related]
28. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
Murga Penas EM; Cools J; Algenstaedt P; Hinz K; Seeger D; Schafhausen P; Schilling G; Marynen P; Hossfeld DK; Dierlamm J
Genes Chromosomes Cancer; 2003 May; 37(1):79-83. PubMed ID: 12661008
[TBL] [Abstract][Full Text] [Related]
29. EHT, a new member of the MTG8/ETO gene family, maps on 20q11 region and is deleted in acute myeloid leukemias.
Fracchiolla NS; Colombo G; Finelli P; Maiolo AT; Neri A
Blood; 1998 Nov; 92(9):3481-4. PubMed ID: 9787195
[No Abstract] [Full Text] [Related]
30. Specialized functions of cohesins STAG1 and STAG2 in 3D genome architecture.
Cuadrado A; Losada A
Curr Opin Genet Dev; 2020 Apr; 61():9-16. PubMed ID: 32294612
[TBL] [Abstract][Full Text] [Related]
31. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
Lindsley RC; Mar BG; Mazzola E; Grauman PV; Shareef S; Allen SL; Pigneux A; Wetzler M; Stuart RK; Erba HP; Damon LE; Powell BL; Lindeman N; Steensma DP; Wadleigh M; DeAngelo DJ; Neuberg D; Stone RM; Ebert BL
Blood; 2015 Feb; 125(9):1367-76. PubMed ID: 25550361
[TBL] [Abstract][Full Text] [Related]
32.
Laczko D; Poveda-Rogers C; Matthews AH; Snaith O; Luger S; Bagg A; Caponetti GC; Morrissette JJD; Yang G
Leuk Lymphoma; 2024 Jul; 65(7):958-964. PubMed ID: 38506144
[TBL] [Abstract][Full Text] [Related]
33. Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation.
Cuartero S; Weiss FD; Dharmalingam G; Guo Y; Ing-Simmons E; Masella S; Robles-Rebollo I; Xiao X; Wang YF; Barozzi I; Djeghloul D; Amano MT; Niskanen H; Petretto E; Dowell RD; Tachibana K; Kaikkonen MU; Nasmyth KA; Lenhard B; Natoli G; Fisher AG; Merkenschlager M
Nat Immunol; 2018 Sep; 19(9):932-941. PubMed ID: 30127433
[TBL] [Abstract][Full Text] [Related]
34. Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies.
Sasca D; Yun H; Giotopoulos G; Szybinski J; Evan T; Wilson NK; Gerstung M; Gallipoli P; Green AR; Hills R; Russell N; Osborne CS; Papaemmanuil E; Göttgens B; Campbell P; Huntly BJP
Blood; 2019 Dec; 134(24):2195-2208. PubMed ID: 31515253
[TBL] [Abstract][Full Text] [Related]
35. Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes.
Ochi Y; Kon A; Sakata T; Nakagawa MM; Nakazawa N; Kakuta M; Kataoka K; Koseki H; Nakayama M; Morishita D; Tsuruyama T; Saiki R; Yoda A; Okuda R; Yoshizato T; Yoshida K; Shiozawa Y; Nannya Y; Kotani S; Kogure Y; Kakiuchi N; Nishimura T; Makishima H; Malcovati L; Yokoyama A; Takeuchi K; Sugihara E; Sato TA; Sanada M; Takaori-Kondo A; Cazzola M; Kengaku M; Miyano S; Shirahige K; Suzuki HI; Ogawa S
Cancer Discov; 2020 Jun; 10(6):836-853. PubMed ID: 32249213
[No Abstract] [Full Text] [Related]
36. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
[TBL] [Abstract][Full Text] [Related]
37. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array.
Martínez-Ramírez A; Urioste M; Melchor L; Blesa D; Valle L; de Andrés SA; Kok K; Calasanz MJ; Cigudosa JC; Benítez J
Genes Chromosomes Cancer; 2005 Mar; 42(3):287-98. PubMed ID: 15611930
[TBL] [Abstract][Full Text] [Related]
38. [An update on epigenetic regulator gene mutations and pathogenesis of myelodysplastic syndromes].
Wang JY; Xiao ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1303-9. PubMed ID: 22040993
[TBL] [Abstract][Full Text] [Related]
39. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
[TBL] [Abstract][Full Text] [Related]
40. De novo loss-of-function variants in STAG2 are associated with developmental delay, microcephaly, and congenital anomalies.
Mullegama SV; Klein SD; Mulatinho MV; Senaratne TN; Singh K; ; Nguyen DC; Gallant NM; Strom SP; Ghahremani S; Rao NP; Martinez-Agosto JA
Am J Med Genet A; 2017 May; 173(5):1319-1327. PubMed ID: 28296084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
